"Click" immobilization on alkylated silicon substrates: model for the study of surface bound antimicrobial peptides.
We describe an effective approach for the covalent immobilization of antimicrobial peptides (AMPs) to bioinert substrates via Cu(I) -catalyzed azide-alkyne cycloaddition (CuAAC). The bioinert substrates were prepared by surface hydrosilylation of oligo(ethylene glycol) (OEG) terminated alkenes on hydrogen-terminated silicon surfaces. To render the OEG monolayers "clickable", mixed monolayers were prepared using OEG-alkenes with and without a terminal alkyne protected by a trimethylgermanyl (TMG) group. The mixed monolayers were characterized by X-ray photoelectron spectroscopy (XPS), elliposometry and contact angle measurement. The TMG protecting group can be readily removed to yield a free terminal alkyne by catalytic amounts of Cu(I) in an aqueous media. This step can then be combined with the subsequent CuAAC reaction. Thus, the immobilization of an azide modified AMP (N3-IG-25) was achieved in a one-pot deprotection/coupling reaction. Varying the ratio of the two alkenes in the deposition mixture allowed for control over the density of the alkynyl groups in the mixed monolayer, and subsequently the coverage of the AMPs on the monolayer. These samples allowed for study of the dependence of antimicrobial activities on the AMP density. The results show that a relative low coverage of AMPs (∼1.6×10(13) molecule per cm(2)) is sufficient to significantly suppress the viability of Pseudomonas aeruginosa, while the surface presenting the highest density of AMPs (∼2.8×10(13) molecule per cm(2)) is still cyto-compatible. The remarkable antibacterial activity is attributed to the long and flexible linker and the site-specific "click" immobilization, which may facilitate the covalently attached peptides to interact with and disrupt the bacterial membranes.
Department of Chemistry & Center for Materials Chemistry, University of Houston, Houston, TX 77204, USA.
Yan
Y
Li
Catherine M
CM
Santos
Amit
A
Kumar
Meirong
M
Zhao
Analette I
AI
Lopez
Guoting
G
Qin
Alison M
AM
McDermott
Chengzhi
C
Cai
D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D057930:Click Chemistry; D003300:Copper / Q000032:analysis; D008954:Models, Biological; D015394:Molecular Structure; D056951:Photoelectron Spectroscopy; D012825:Silicon / Q000737:chemistry* / Q000494:pharmacology*; D054804:Cathelicidins
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; C556980:I-G-K-E-F-K-R-I-V-Q-R-I-K-D-F-L-R-N-L-V-P-R-T-E-S; D003300:Copper; D012825:Silicon; D054804:Cathelicidins
J Antimicrob Chemother. 2002 Sep;50(3):339-48
12205058
Antimicrob Agents Chemother. 1995 Feb;39(2):301-7
7726486
Nat Rev Microbiol. 2004 Feb;2(2):95-108
15040259
Biofouling. 2008;24(6):439-48
18696290
Toxicology. 1997 Dec 31;124(3):179-92
9482120
Antimicrob Agents Chemother. 2009 Mar;53(3):1132-41
19104020
Angew Chem Int Ed Engl. 2009;48(52):9879-83
19943299
Langmuir. 2009 Jan 20;25(2):1060-7
19177651
Science. 1987 Sep 25;237(4822):1588-95
3629258
Angew Chem Int Ed Engl. 2001 Jun 1;40(11):2004-2021
11433435
Chem Rev. 2008 Aug;108(8):2952-3015
18698735
Langmuir. 2006 Mar 14;22(6):2457-64
16519441
J Am Chem Soc. 2010 Nov 24;132(46):16432-41
21033708
Antimicrob Agents Chemother. 2005 Jul;49(7):2845-50
15980359
Biomaterials. 2009 Jul;30(21):3503-12
19345992
Appl Environ Microbiol. 2005 Mar;71(3):1130-4
15746309
Appl Environ Microbiol. 1991 Nov;57(11):3243-7
1723585
Nat Med. 2006 Jun;12(6):636-41
16751768
Bioconjug Chem. 2009 Jan;20(1):71-7
19113948
Clin Microbiol Rev. 2006 Jul;19(3):491-511
16847082
J Mol Med (Berl). 2008 Jan;86(1):37-47
17805504
J Appl Microbiol. 2008 Dec;105(6):1817-25
19016975
Biomaterials. 2003 May;24(11):1959-67
12615486
Bioconjug Chem. 2006 Mar-Apr;17(2):548-50
16536489
Biopolymers. 1998;47(6):451-63
10333737
Anal Chem. 2005 Oct 1;77(19):6504-8
16194120
Biomaterials. 2004 May;25(11):2003-11
14741614
Chem Biol. 2009 Jan 30;16(1):58-69
19171306
Emerg Infect Dis. 2002 Sep;8(9):881-90
12194761
Expert Opin Investig Drugs. 2006 Aug;15(8):933-46
16859395
J Biomed Mater Res. 2000 Sep 5;51(3):343-51
10880075
Antimicrob Agents Chemother. 2004 Oct;48(10):3662-9
15388417
J Am Chem Soc. 2006 May 3;128(17):5776-85
16637646
Acc Chem Res. 2010 Jan 19;43(1):30-9
19813703
J Am Chem Soc. 2007 May 2;129(17):5370-1
17425323
J Biol Chem. 2008 Nov 21;283(47):32637-43
18818205
Emerg Infect Dis. 1998 Oct-Dec;4(4):551-60
9866731
Biochemistry. 1995 Mar 14;34(10):3423-9
7533538
J Biol Chem. 1996 Nov 29;271(48):30493-8
8940016
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19207-12
20956332
Org Lett. 2004 Aug 19;6(17):2853-5
15330631
Nat Prod Rep. 2009 Dec;26(12):1572-84
19936387
Chem Commun (Camb). 2009 May 28;(20):2854-6
19436888
Langmuir. 2007 Aug 28;23(18):9320-9
17655337
Chem Commun (Camb). 2004 Nov 7;(21):2510-1
15514840
J Am Chem Soc. 2004 Aug 4;126(30):9152-3
15281783
Biomaterials. 2005 Nov;26(33):6704-12
15992921
Macromolecules. 1998 Jul 28;31(15):5059-70
9680446
Nature. 2002 Jan 24;415(6870):389-95
11807545
Science. 1999 May 21;284(5418):1318-22
10334980
J Am Chem Soc. 2004 Jul 7;126(26):8098-9
15225034
Curr Eye Res. 2005 Jul;30(7):505-15
16020284
Angew Chem Int Ed Engl. 2008;47(46):8831-4
18846530
Int J Antimicrob Agents. 1999 May;11(3-4):217-21; discussion 237-9
10394973